LLY Earnings
Latest Revenue19.8B
Latest Net Income7.4B
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q1 2026 | $8.27 | 19.8B | 7.4B | +55.5% | +169.4% |
| Q4 2025 | $7.41 | 19.3B | 6.6B | +42.6% | +51.2% |
| Q3 2025 | $6.22 | 17.6B | 5.6B | +53.9% | +475.9% |
| Q2 2025 | $6.30 | 15.6B | 5.7B | +37.6% | +91.5% |
| Q1 2025 | $3.07 | 12.7B | 2.8B | +45.2% | +23.3% |
| Q4 2024 | $4.90 | 13.5B | 4.4B | +44.7% | +101.6% |
| Q3 2024 | $1.08 | 11.4B | 970.3M | +20.4% | +1,900.0% |
| Q2 2024 | $3.29 | 11.3B | 3.0B | +36.0% | +67.9% |
| Q1 2024 | $2.49 | 8.8B | 2.2B | — | — |
| Q4 2023 | $2.43 | 9.4B | 2.2B | — | — |
| Q3 2023 | -$0.06 | 9.5B | -57400000 | — | — |
| Q2 2023 | $1.96 | 8.3B | 1.8B | — | — |
Eli Lilly & (LLY) — Earnings